Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis a 2023 TBnetRESISTTB consensus statement

Simple item page
dc.article.end-page137en
dc.article.start-page122en
dc.citation.doi10.1016/S1473-3099(22)00875-1en
dc.contributor.authorJose Domínguezen
dc.contributor.authorM Boereeen
dc.contributor.authorEmmanuelle Cambauen
dc.contributor.authorDumitru Chesoven
dc.contributor.authorFrancesca CONRADIEen
dc.contributor.authorE et alen
dc.date.accessioned2024-07-23T06:01:42Z
dc.date.available2024-07-23T06:01:42Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1473-3099en
dc.identifier.urihttps://hdl.handle.net/10539/39688
dc.journal.titleClinical implications of molecular drug resistance testing for Mycobacterium tuberculosis a 2023 TBnetRESISTTB consensus statementen
dc.journal.volume23en
dc.publisherELSEVIER SCIENCE INCen
dc.titleClinical implications of molecular drug resistance testing for Mycobacterium tuberculosis a 2023 TBnetRESISTTB consensus statementen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.95 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)